Yunhong Lu

1.2k total citations · 1 hit paper
12 papers, 917 citations indexed

About

Yunhong Lu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Anesthesiology and Pain Medicine. According to data from OpenAlex, Yunhong Lu has authored 12 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Anesthesiology and Pain Medicine. Recurrent topics in Yunhong Lu's work include Diabetes Treatment and Management (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Airway Management and Intubation Techniques (2 papers). Yunhong Lu is often cited by papers focused on Diabetes Treatment and Management (4 papers), Metabolism, Diabetes, and Cancer (3 papers) and Airway Management and Intubation Techniques (2 papers). Yunhong Lu collaborates with scholars based in China and Czechia. Yunhong Lu's co-authors include Ying Cheng, Mei Xue, Liming Chen, Bei Sun, Xiaochen Yu, Fei Han, Linxin Xu, Xiangyang Liu, Yunpeng Chang and Jie Zhang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Diabetologia and Frontiers in Pharmacology.

In The Last Decade

Yunhong Lu

12 papers receiving 911 citations

Hit Papers

SGLT2 inhibition with empagliflozin attenuates myocardial... 2019 2026 2021 2023 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
    2019 442 citations Chenguang Li, Jie Zhang et al. Cardiovascular Diabetology profile →

Peers

Yunhong Lu
Linxin Xu China
Xiaochen Yu China
Xiaohan Lu United States
Meliana Riwanto Switzerland
Ornella Carbonara Italy
Mizuo Mifune Japan
Rio P. Juni Netherlands
Agnès Sassolas France
Motofumi Sasaki Japan
Mitchel Tate Australia
Linxin Xu China
Yunhong Lu
Citations per year, relative to Yunhong Lu Yunhong Lu (= 1×) peers Linxin Xu

Countries citing papers authored by Yunhong Lu

Since Specialization
Citations

This map shows the geographic impact of Yunhong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunhong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunhong Lu more than expected).

Fields of papers citing papers by Yunhong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunhong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunhong Lu. The network helps show where Yunhong Lu may publish in the future.

Co-authorship network of co-authors of Yunhong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunhong Lu. A scholar is included among the top collaborators of Yunhong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunhong Lu. Yunhong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Lu, Yunhong, Yunpeng Chang, Ting Li, et al.. (2020). Empagliflozin Attenuates Hyperuricemia by Upregulation of ABCG2 via AMPK/AKT/CREB Signaling Pathway in Type 2 Diabetic Mice. International Journal of Biological Sciences. 16(3). 529–542. 90 indexed citations
3.
Xue, Mei, Ting Li, Yue Wang, et al.. (2019). Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice. Clinical Science. 133(15). 1705–1720. 85 indexed citations
4.
Cheng, Ying, Xiaochen Yu, Jie Zhang, et al.. (2019). Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes. Diabetologia. 62(6). 1074–1086. 63 indexed citations
5.
Li, Chenguang, Jie Zhang, Mei Xue, et al.. (2019). SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovascular Diabetology. 18(1). 15–15. 442 indexed citations breakdown →
6.
Wang, Yue, Yunhong Lu, Chao Tang, et al.. (2019). Calcium Dobesilate Restores Autophagy by Inhibiting the VEGF/PI3K/AKT/mTOR Signaling Pathway. Frontiers in Pharmacology. 10. 886–886. 45 indexed citations
7.
8.
Li, Xiaoyu, Ting Li, Ying Cheng, et al.. (2019). Effects of SGLT2 inhibitors on fractures and bone mineral density in type 2 diabetes: An updated meta‐analysis. Diabetes/Metabolism Research and Reviews. 35(7). e3170–e3170. 51 indexed citations
9.
Cheng, Lihong, et al.. (2019). Air Embolism during Upper Endoscopy: A Case Report. Clinical Endoscopy. 52(4). 365–368. 4 indexed citations
10.
Xue, Mei, Ying Cheng, Fei Han, et al.. (2018). Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease. International Journal of Biological Sciences. 14(11). 1545–1557. 93 indexed citations
11.
Yang, Yang, Yunhong Lu, Fei Han, et al.. (2018). Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD. Biochemical and Biophysical Research Communications. 503(3). 1618–1624. 31 indexed citations
12.
Lu, Yunhong, et al.. (2014). [XCT790 inhibits rat vascular smooth muscle cells proliferation through down-regulating the expression of estrogen-related receptor alpha].. PubMed. 49(2). 190–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linxin Xu Breakdown of academic impact, for papers by Xiaochen Yu Breakdown of academic impact, for papers by Xiaohan Lu Breakdown of academic impact, for papers by Meliana Riwanto Breakdown of academic impact, for papers by Ornella Carbonara Breakdown of academic impact, for papers by Mizuo Mifune Breakdown of academic impact, for papers by Rio P. Juni Breakdown of academic impact, for papers by Agnès Sassolas Breakdown of academic impact, for papers by Motofumi Sasaki Breakdown of academic impact, for papers by Mitchel Tate
Rankless by CCL
2026